Entities / Company
Elanco.
American healthcare company
- Reports this week
- 0
- Active events
- 0
- Connections
- 80
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
One to three months ago
-
Elanco, a company based in Indianapolis, filed required documents with the SEC on August 19, 2026.Some support1 report
-
Elanco filed required insider trading disclosures with the relevant authorities on August 18, 2026.Some support1 report
-
Elanco reported market share gains driven by its successful innovation portfolio within the animal health industry.Some support3 reports
-
CEO Jeffrey N. Simmons purchased Elanco shares, and Norges Bank acquired a new stake in the company, disclosed via SEC filing.Some support1 report
Gone quiet
No new reports in 90+ days-
FDA approved combination clearances for Elanco's Experior use on June 27, 2025.Some support2 reports
-
Elanco Ventures established a CVC platform in Indianapolis to invest in animal health, leveraging the One Health Innovation District.Some support1 report
-
Elanco leverages proximity of partnerships in Indianapolis.Some support2 reports
-
Microsoft, Elanco, Monster Beverage, and Jazz Pharmaceuticals were cited in thematic investing as examples of diverse winners in the pharmaceuticals segment.Some support2 reports
-
Elanco was originally a division of Eli Lilly, and Jeff Simmons currently serves as the President and CEO of Elanco.Some support9 reports
-
Trump pledged to unleash American oil and gas production, involving Elanco.Some support1 report
-
Bank of America probed Elanco regarding its innovation revenue guidance on June 30, 2025.Speculative1 report
-
Global license agreement accelerates commercialization of NUZ-001 for neurodegenerative diseases.Speculative1 report
-
Elanco developed a vaccine for canine influenza protection and received approval from the USDA for market release.Speculative2 reports
-
Elanco, Zoetis, and Boehringer Ingelheim are noted for their leadership in the veterinary dermatology market.Some support1 report
-
Elanco and U.S. Physical Therapy were classified as stocks in the Medical Healthcare sector as of July 24, 2025.Some support1 report
-
Elanco secures various market approvals for its product Zenrelia, including availability in the US, EU, Brazil, Canada, and Japan.Some support1 report
-
Wall Street analysts predicted specific quarterly earnings and revenue metrics for Elanco.Some support1 report
-
Elanco's stock performance was compared to the broader market index on August 7, 2025.Some support1 report
-
Accelerated customer purchases in China benefited sales for a company, while Quattro saw increased sell-through in the U.S., coinciding with a comment from William Blair on Elanco's earnings.Some support1 report
-
Elanco attended a conference hosted by Morgan Stanley on August 26, 2025.Some support2 reports
-
Elanco and Splenda announced support for the Nutrition Secure Indianapolis program, marking a specific corporate action in the city.Some support1 report
-
Elanco is joining the S&P MidCap 400 index, Boehringer Ingelheim launched a new swine vaccine, and Sarepta Therapeutics is being replaced in the index.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Elanco this week
News at the entities that move Elanco most-
SEC StructuralDHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Moves Elanco
-
Eli Lilly and Company StructuralExxonMobil, Berkshire Hathaway, and Eli Lilly are top holdings in the Avantis ETF.Moves Elanco
-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Elanco
-
Jazz Pharmaceuticals OperationalJazz Pharmaceuticals plans U.S. launch of Ziihera.Moves Elanco
-
Lancaster County Shared contextA situation in Lancaster County, Pennsylvania, accounted for 24 percent of the national total on September 27th.Moves Elanco
-
Norges Bank TransactionalNorges Bank bought a new position in Qualcomm shares, coinciding with buy ratings and price targets from TD Cowen, reported by MarketBeat.Moves Elanco
Connections
The 19 strongest of 80, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Eli Lilly and Company Structural
Elanco was historically a division and subsidiary of Eli Lilly and Company.
-
Jeffrey N. Simmons Structural
Jeffrey N. Simmons serves as the CEO of Elanco.
-
Jeff Simmons Structural
Jeff Simmons holds the executive leadership role of CEO and President at Elanco.
-
SEC Structural
Elanco is subject to mandatory disclosure and regulatory oversight by the SEC.
-
Zoetis Operational
Elanco and Zoetis are direct competitors operating in the animal health and veterinary dermatology markets.
-
FDA Structural
The FDA provides necessary regulatory clearances and oversight for Elanco's products and market operations.
-
Todd Young Operational
Todd Young served as an advisor and CFO for Elanco, managing cost control.
-
Jazz Pharmaceuticals Operational
The two companies actively compete and operate within the specialized pharmaceutical market segment.
Show all 19 connections
-
Indianapolis Shared context
Elanco operates within the specific programs, partnerships, and innovation districts of Indianapolis.
-
Kelso Transactional
Elanco sponsors the Kelso Ram Sales event.
-
Norges Bank Transactional
Norges Bank acquired a new stake in Elanco.
-
Indiana Mentioned together
The relationship is based on the shared context that Indiana possesses expertise in human, animal, and plant health.
-
Lancaster County Shared context
The relationship is defined by a shared local context through involvement in the Library Board of Trustees in Lancaster County.
-
Monster Beverage Mentioned together
The entities are co-mentioned in articles grouping them thematically as diverse growth stocks and winners.
-
Doniphan County Shared context
Elanco's expansion provides economic benefits to Doniphan County.
-
Buy Shared context
Elanco conducts business operations within the location of Buy, as required for insider trading disclosures.
-
Kansas Shared context
Elanco utilizes a manufacturing site located within the state of Kansas.
-
Texas Shared context
Elanco operates within the agricultural context of Texas, where livestock health issues occur.
-
Centers for Disease Control Mentioned together
The provided evidence does not describe any relationship or coupling between the Centers for Disease Control and Elanco.
History
Events by the month they beganAugust 2026
4 events- Elanco is utilizing a manufacturing site in Doniphan County, Kansas, and the expansion is expected to benefit the local county economy.
- Elanco, a company based in Indianapolis, filed required documents with the SEC on August 19, 2026.
- Elanco filed required insider trading disclosures with the relevant authorities on August 18, 2026.
- Elanco reported market share gains driven by its successful innovation portfolio within the animal health industry.
July 2026
1 eventJune 2026
18 events- FDA approved combination clearances for Elanco's Experior use on June 27, 2025.
- Elanco Ventures established a CVC platform in Indianapolis to invest in animal health, leveraging the One Health Innovation District.
- Elanco leverages proximity of partnerships in Indianapolis.
- Microsoft, Elanco, Monster Beverage, and Jazz Pharmaceuticals were cited in thematic investing as examples of diverse winners in the pharmaceuticals segment.
- Elanco was originally a division of Eli Lilly, and Jeff Simmons currently serves as the President and CEO of Elanco.
- Trump pledged to unleash American oil and gas production, involving Elanco.
- Bank of America probed Elanco regarding its innovation revenue guidance on June 30, 2025.
- Global license agreement accelerates commercialization of NUZ-001 for neurodegenerative diseases.
- Elanco developed a vaccine for canine influenza protection and received approval from the USDA for market release.
- Elanco, Zoetis, and Boehringer Ingelheim are noted for their leadership in the veterinary dermatology market.
- Elanco and U.S. Physical Therapy were classified as stocks in the Medical Healthcare sector as of July 24, 2025.
- Elanco secures various market approvals for its product Zenrelia, including availability in the US, EU, Brazil, Canada, and Japan.
- Wall Street analysts predicted specific quarterly earnings and revenue metrics for Elanco.
- Elanco's stock performance was compared to the broader market index on August 7, 2025.
- Accelerated customer purchases in China benefited sales for a company, while Quattro saw increased sell-through in the U.S., coinciding with a comment from William Blair on Elanco's earnings.
- Elanco attended a conference hosted by Morgan Stanley on August 26, 2025.
- Elanco and Splenda announced support for the Nutrition Secure Indianapolis program, marking a specific corporate action in the city.
- Elanco is joining the S&P MidCap 400 index, Boehringer Ingelheim launched a new swine vaccine, and Sarepta Therapeutics is being replaced in the index.